# Evaluation of Symptom-specific Goal Achievement

> **NCT00836823** · PHASE4 · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 130 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia
- Lower Urinary Tract Symptoms

## Interventions

- **DRUG:** Alfuzosin

## Key facts

- **NCT ID:** NCT00836823
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2023-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00836823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00836823, "Evaluation of Symptom-specific Goal Achievement". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT00836823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*